Filing Details

Accession Number:
0001209191-16-114344
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-15 14:29:05
Reporting Period:
2016-04-14
Filing Date:
2016-04-15
Accepted Time:
2016-04-15 14:29:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175505 Five Prime Therapeutics Inc FPRX Pharmaceutical Preparations (2834) 260038620
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1475714 T Lewis Williams Two Corporate Drive
South San Francisco CA 94080
President, Ceo And Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-14 2,725 $8.49 343,253 No 4 M Direct
Common Stock Disposition 2016-04-14 2,725 $48.00 340,528 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2016-04-14 2,725 $0.00 2,725 $8.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
66,425 2021-10-19 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 4, 2015.
  2. This option is fully vested and immediately exercisable.